Biolase, Inc.
BIOL
BIOL was delisted on the 18th of June, 2024.
34 hedge funds and large institutions have $33.3M invested in Biolase, Inc. in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 15 closing their positions.
18% less capital invested
Capital invested by funds: $40.6M → $33.3M (-$7.3M)
23% less funds holding
Funds holding: 44 → 34 (-10)
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $75K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$306K |
| 2 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$306K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$230K |
| 4 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
+$204K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
+$153K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.81M |
| 2 |
State Street
Boston,
Massachusetts
|
-$817K |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$587K |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$309K |
| 5 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
-$204K |
BIOL Hedge Fund Activity: Q2 2014 in Review
34 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q2 2014, worth a combined $33.3M — down 18% from $40.6M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of BIOL and 5 opened new positions — a net loss of 10 holders — while 11 trimmed existing stakes and 7 added.
The largest buyer was Deutsche Bank, adding an estimated $306K. The largest seller was BlackRock Fund Advisors, cutting an estimated $1.81M.
- 34 institutional investors held Biolase, Inc. (BIOL) as of Q2 2014, down from 44 in Q1 2014.
- Funds reported $33.3M of Biolase, Inc. stock for Q2 2014, down 18% quarter-over-quarter.
- 5 funds opened new Biolase, Inc. positions in Q2 2014 and 15 closed out, a net change of -10 holders.
- The largest Biolase, Inc. buyer in Q2 2014 was Deutsche Bank, an estimated $306K added.
- The largest Biolase, Inc. seller in Q2 2014 was BlackRock Fund Advisors, an estimated $1.81M sold.
Based on aggregated 13F filings for Q2 2014.